Chubb Stock Jumps After Buffett's Berkshire Takes a Stake
Chubb stock is up on news Warren Buffett's holding company Berkshire Hathaway built a position in the insurance firm. Here's what you need to know.
Chubb (CB) stock is trading comfortably higher Thursday on news Warren Buffett's Berkshire Hathaway (BRK.B) holding company built a new position in the insurance firm.
In the most recent Securities and Exchange Commission (SEC) Form 13-F filing that revealed all the stocks Buffett is buying and selling, released late Wednesday, Berkshire Hathaway disclosed that it bought 25.9 million CB shares. This was worth a market value of roughly $6.7 billion as of March 31, 2024, or a 6.1% stake in the company.
Berkshire Hathaway began buying Chubb shares in the third quarter of 2023 and received permission from regulators to keep the holding confidential until it was done building its stake, according to CNBC.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
At the end of Q1 2024, Chubb was the ninth largest position in the Berkshire Hathaway equity portfolio, with a 2.0% weight.
The property and casualty insurer fits well within the Berkshire wheelhouse. Not only is Berkshire the parent company of insurance firms GEICO and Alleghany, but there are several large-cap financial stocks included in the equity portfolio, such as Bank of America (BAC) and Aon (AON).
The news of Berkshire's position in Chubb comes just weeks after the holding company's annual meeting, where Buffett said it reduced its stake in Apple (AAPL) by 13%. Even after this reduction Apple is still Berkshire's largest position, representing about 40% of the portfolio at the end of Q1 2024.
Where does Chubb stand with analysts?
Analysts are positive on the insurance giant. According to S&P Global Market Intelligence, the consensus analyst target price for CB stock is $268.36, representing implied upside of more than 2% to current levels. Meanwhile, the consensus recommendation is Buy.
Independent research firm Argus Research is one of the more bullish outfits on Chubb stock with a Buy rating and a recently increased price target.
"A provider of property and casualty and health/life insurance, as well as reinsurance, Chubb benefits from a strong brand, an experienced management team, and a healthy balance sheet," Argus said in a May 10 report. "We are raising our target price to $280 from $270."
The $280 price target represents implied upside of about 7% to current levels.
Related Content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Twilio Stock Soars on Strong Profit Forecasts: What to Know
Twilio stock is one of the best-performing stocks Friday after the tech company revealed its three-year profit forecast at an investor event.
By Joey Solitro Published
-
Novo Nordisk Stock Surges On Weight Loss Drug Data and Analysts Say It's Still a Buy
Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight loss drug. Here's what you need to know.
By Joey Solitro Published
-
Twilio Stock Soars on Strong Profit Forecasts: What to Know
Twilio stock is one of the best-performing stocks Friday after the tech company revealed its three-year profit forecast at an investor event.
By Joey Solitro Published
-
Novo Nordisk Stock Surges On Weight Loss Drug Data and Analysts Say It's Still a Buy
Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight loss drug. Here's what you need to know.
By Joey Solitro Published
-
Verizon Sails to the Top of the Dow After Earnings Beat: What to Know
Verizon stock is one of the best Dow Jones stocks Friday after the telecommunications giant beat estimates for its fourth quarter. Here's what you need to know.
By Joey Solitro Published
-
What American Express' Latest Dividend Hike Means for Investors
In addition to an earnings beat, American Express disclosed a 17% increase to its quarterly dividend. Here's what that means for the Dow Jones stock.
By Joey Solitro Published
-
Secure Your Retirement Paycheck: The Power of Three Buckets
Putting all of your nest egg in one basket is risky. Try putting it in three buckets for short-term, medium-term and long-term needs instead.
By Pete Tychsen, Investment Adviser Representative Published
-
Five Reasons You Might Hate Your Insurance Company (and Why You Shouldn't)
Stories about insurance companies letting down their customers are easy to come by, but there's another side to many of those stories.
By Karl Susman, CPCU, LUTCF, CIC, CSFP, CFS, CPIA, AAI-M, PLCS Published
-
Stock Market Today: Dow Adds 408 Points as Trump Answers Davos Questions
Tech stocks surged late and the S&P 500 established its first new all-time closing high of 2025.
By David Dittman Published
-
EA Stock Crashes on Earnings Warning. Should Investors Be Worried?
EA stock is spiraling Thursday after video game maker Electronic Arts released preliminary quarterly numbers and lowered its full-year bookings guidance.
By Joey Solitro Published